Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BIOLASE Inc (NASDAQ:BIOL)

1.93
Delayed Data
As of Sep 23
 +0.05 / +2.66%
Today’s Change
0.60
Today|||52-Week Range
1.95
+129.46%
Year-to-Date
No recent news for BIOLASE Inc.

Today’s Trading

Previous close1.88
Today’s open1.90
Day’s range1.88 - 1.94
Volume79,438
Average volume (3 months)83,530
Market cap$113.3M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+22.22%
Earnings growth (this year)+60.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+1.62%
P/E ratioNM
Price/Sales1.02
Price/Book4.51

Competitors

 Today’s
change
Today’s
% change
MLSSMilestone Scientific...+0.13+6.67%
PDEXPro-Dex Inc+0.08+1.64%
ALGNAlign Technology Inc-1.54-1.61%
XRAYDentsply Sirona Inc-0.65-1.08%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)$0.00
Annual revenue (last year)$48.1M
Annual profit (last year)-$20.3M
Net profit margin-42.15%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Harold C. Flynn
Vice President-
Operations
Richard R. Whipp
Corporate headquarters
Irvine, California

Forecasts

Search for Jobs